PGEN Jeffrey B Kindler sells $243K worth of shares
Oct 02, 2025, 4:34 AM
0.00%
What does PGEN do
Precigen, a biotechnology company headquartered in Germantown, Maryland, focuses on synthetic biology technologies and develops therapies for urgent diseases. Founded in 2013, it operates through Biopharmaceuticals and Exemplar segments.
Jeffrey B Kindler sold 67,523 shares of PGEN on 29 September at $3.60 per share, worth a total of $243K. They now own 452,907 PGEN shares, or a 13% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.